Post-ASCO Update: Phase 3 VERIFY Study Results Protagonist Therapeutics, Inc. Newark, CA June 2, 2025 Forward-looking Statements This presentation and the accompanying oral presentation contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our future results of operations and financial position, business stra ...

Protagonist Therapeutics (PTGX) Update / Briefing February 06, 2025 10:30 AM ET Speaker0 Good morning, everybody. Thanks for joining us. I'm Corey Davis with LifeSci Advisors. Welcome to our PV Day with Protagonist Therapeutics to review the current PV market and set the stage for the upcoming Phase III data that are expected in March. We have got two KOLs and a number of company executives to walk through what I hope will be a scintillating presentation. We've got about 40 people in the room and over 100 p ...